X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs AJANTA PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE AJANTA PHARMA CADILA HEALTHCARE/
AJANTA PHARMA
 
P/E (TTM) x 34.3 20.7 165.8% View Chart
P/BV x 8.8 9.0 98.8% View Chart
Dividend Yield % 0.7 0.7 103.2%  

Financials

 CADILA HEALTHCARE   AJANTA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
AJANTA PHARMA
Mar-16
CADILA HEALTHCARE/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4541,720 26.4%   
Low Rs3051,103 27.6%   
Sales per share (Unadj.) Rs96.1194.6 49.4%  
Earnings per share (Unadj.) Rs14.945.2 32.9%  
Cash flow per share (Unadj.) Rs17.850.3 35.4%  
Dividends per share (Unadj.) Rs3.208.00 40.0%  
Dividend yield (eoy) %0.80.6 148.8%  
Book value per share (Unadj.) Rs52.3132.0 39.6%  
Shares outstanding (eoy) m1,023.7488.77 1,153.2%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.97.3 54.4%   
Avg P/E ratio x25.531.2 81.7%  
P/CF ratio (eoy) x21.328.1 75.9%  
Price / Book Value ratio x7.310.7 67.9%  
Dividend payout %21.517.7 121.6%   
Avg Mkt Cap Rs m388,458125,299 310.0%   
No. of employees `00015.4NA-   
Total wages/salary Rs m13,3172,570 518.2%   
Avg. sales/employee Rs Th6,371.1NM-  
Avg. wages/employee Rs Th862.4NM-  
Avg. net profit/employee Rs Th986.1NM-  
INCOME DATA
Net Sales Rs m98,37617,275 569.5%  
Other income Rs m941166 565.8%   
Total revenues Rs m99,31717,442 569.4%   
Gross profit Rs m23,8295,807 410.3%  
Depreciation Rs m3,022451 670.7%   
Interest Rs m48649 993.9%   
Profit before tax Rs m21,2625,474 388.4%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-250-   
Tax Rs m5,7161,460 391.5%   
Profit after tax Rs m15,2264,014 379.3%  
Gross profit margin %24.233.6 72.1%  
Effective tax rate %26.926.7 100.8%   
Net profit margin %15.523.2 66.6%  
BALANCE SHEET DATA
Current assets Rs m44,3767,639 580.9%   
Current liabilities Rs m34,0712,715 1,255.1%   
Net working cap to sales %10.528.5 36.8%  
Current ratio x1.32.8 46.3%  
Inventory Days Days5443 124.6%  
Debtors Days Days6279 79.2%  
Net fixed assets Rs m47,8966,914 692.8%   
Share capital Rs m1,024177 578.9%   
"Free" reserves Rs m48,74611,442 426.0%   
Net worth Rs m53,51911,721 456.6%   
Long term debt Rs m8,964149 6,028.2%   
Total assets Rs m100,16314,814 676.1%  
Interest coverage x44.7112.9 39.6%   
Debt to equity ratio x0.20 1,320.2%  
Sales to assets ratio x1.01.2 84.2%   
Return on assets %15.727.4 57.2%  
Return on equity %28.434.2 83.1%  
Return on capital %34.346.5 73.7%  
Exports to sales %45.355.1 82.1%   
Imports to sales %5.96.0 98.8%   
Exports (fob) Rs m44,5379,527 467.5%   
Imports (cif) Rs m5,8381,038 562.6%   
Fx inflow Rs m44,88110,422 430.6%   
Fx outflow Rs m9,0691,678 540.4%   
Net fx Rs m35,8128,744 409.6%   
CASH FLOW
From Operations Rs m19,9383,264 610.9%  
From Investments Rs m-9,039-2,093 431.9%  
From Financial Activity Rs m-9,527-1,186 803.5%  
Net Cashflow Rs m1,372-15 -9,270.3%  

Share Holding

Indian Promoters % 74.8 73.8 101.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 1.6 535.5%  
FIIs % 5.9 7.6 77.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.0 64.7%  
Shareholders   44,069 20,968 210.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DR. DATSONS LABS  STRIDES SHASUN LTD  FULFORD INDIA  JUBILANT LIFE SCIENCES  BIOCON LTD  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 23, 2017 03:36 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS